Many studies have evaluated the use of anti-VEGF agents as adjuncts in tube shunt surgery for NVG, but only a few small studies have examined their use for the same procedures in other forms of glaucoma [38, 39]. The gene discussed is VEGFA; the disease is glaucoma.